인쇄하기
취소

Huons, Fresenius Kabi Korea sign deal to sell anesthetic drug

Published: 2012-05-22 06:56:00
Updated: 2012-05-22 06:56:00
Huons said Thursday it established a strategic partnership with Fresenius Kabi Korea to sell an anesthetic drug.

Under the deal, Huons will be in charge of selling Fresopol (propofol) MCT injection 1% (15 mL and 20 mL) through its extensive domestic clinics, with Fresenius Kabi Korea responsible for marketing efforts in general hospitals.

Propofol is a short-acting, intravenously administ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.